API
Director Trades
| Date | Director | Value |
|---|
Company News
Huge battle brewing over the future direction of pharmacies in Australia
During the COVID-19 pandemic, a trip to the pharmacy became one of the few shopping highlights that was allowed during the many lockdowns. However, it wasn’t just shoppers who were taking notice of the central role pharmacies play in retailing but also the big companies that own massive chunks of our existing retail chains. Wesfarmers […]
Get bigger or pay money to shareholders – the choice facing companies
It has been a great time to be a shareholder with Australian companies increasingly stuffed with cash which they will now be looking to put to use. Those shareholders may selfishly hope that a lot of that cash will be heading in their direction – either in the form of bumper dividends or share buybacks […]
AusCann reports successful study in ‘game changer’ cannabinoid capsules
AusCann (ASX: AC8) is a step closer to releasing its proprietary cannabinoid capsules to world markets after a “successful” pilot study into its optimum final dose. The company has been carrying out the study over the last 10 months, with the aim of launching its medical cannabis products to world markets in the first half […]
AusCann strikes distribution agreement with ASX-listed Australian Pharmaceutical Industries
AusCann Group (ASX: AC8), a leading Australian medicinal cannabis company, has announced a Heads of Agreement (HoA) with ASX-listed Australian Pharmaceutical Industries Limited (ASX: API). The deal will see API distribute AusCann’s cannabinoid medicines throughout Australia and establish long-lasting distribution channels for the supply of AusCann’s medications to Australian patients. News of today’s HoA saw […]